Skip to content

AMERIPRISE FINANCIAL INC: MXCT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of AMERIPRISE FINANCIAL INC on MXCT, newest first. How the timeline and the estimate are built.

AMERIPRISE FINANCIAL INC held 79,472 MXCT shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 79,472 shares
    Change vs previous 13F -64,615 shares

    <0.01% of the 13F portfolio, value $97,751.

    13F-HR 0001193125-26-351426 filed by AMERIPRISE FINANCIAL INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F/A 144,087 shares
    Change vs previous 13F -29,886 shares

    <0.01% of the 13F portfolio, value $101,221.

    13F-HR/A 0001193125-26-307051 filed by AMERIPRISE FINANCIAL INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 173,973 shares
    Change vs previous 13F +173,973 shares

    <0.01% of the 13F portfolio, value $269,658.

    13F-HR 0001193125-26-053888 filed by AMERIPRISE FINANCIAL INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 0 shares
    Change vs previous 13F -1,116,300 shares

    13F-HR 0000950123-25-002497 filed by AMERIPRISE FINANCIAL INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2024-09-30
    13F 1,116,300 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $4,342,405.

    13F-HR 0000950123-24-011620 filed by AMERIPRISE FINANCIAL INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).